Skip to Main Content
November 7, 2025
Health Law Weekly

Featured Articles

CMS Issues CY 2026 Physician Fee Schedule Final Rule

Evolving Expectations: Medicare Advantage Compliance for Plans and Providers

Health Care Corporate Governance: NACD’s Report on the Board/Management Dynamic

Current Topics

Antitrust

U.S. Court in Connecticut Won’t Nix Multi-State Action Alleging Price-Fixing of Generic Dermatological Products

Fraud and Compliance

Addiction Treatment Center Owner Charged with Medicaid Fraud

Fifth Circuit Tosses Whistleblower Action Against IRF, One Judge Calls for Reconsidering Constitutionality of Qui Tam Provisions

Nine Pharmacies Resolve Allegations of Improperly Billing Medicaid for COVID-19 Tests

Nurse Staffing Agency, Owner, and Employee Charged in Fraud Scheme

SuperValu Sheds Drug Pricing Fraud Whistleblower Action

Government Reimbursement

CMS to Pilot MFN Pricing in New Medicaid Drug Payment Model

Health Care Finance and Transactions

Kimberly-Clark to Acquire Tylenol Maker Kenvue

Health Law Policy and Administration Hub

All 50 States Apply for a Share of Rural Health Fund, CMS Says

Life Sciences

FDA Adds More Priority Vouchers, Including for Orforglipron, Wegovy

Trump Touts Lower Prices, Medicare Coverage for Weight-Loss Drugs in Deals with Eli Lilly, Novo Nordisk

U.S. Court in Colorado Refuses to Block State Law Prohibiting 340B Contract Pharmacy Limits

U.S. Court in Oklahoma Blocks State Law Prohibiting 340B Contract Pharmacy Limits

Reproductive Health Law Hub

New York Court Denies Texas’ Bid to Enforce Default Judgment Against Physician over Remote Abortion Pill Prescription

U.S. Court in Hawaii Finds Mifepristone Safety Restrictions Unlawful, Remands to FDA for Further Consideration
Current Issue
Health Law Weekly Issue - November 7, 2025